EU backs J&J COVID-19 vaccine despite blood clot risk

EU backs J&J COVID-19 vaccine despite blood clot risk

The EMA found that all instances of clotting had occurred in adults under 60 years, mostly women, within three weeks of vaccination with J&J's single shot.